Aerocrine: The latest share price. Save Reset. Aerocrine (AERO). kr n/a. % kr Today’s Low & High; n/a / n/a. Open / Previous Close; n/a / Aerocrine AB researches, developes, and sells systems and products for measuring airway inflammation. The Company has developed a method for diagnosing. Aerocrine Ab (GM) historical price data and ACNOY charts. Free real-time prices, trades, and chat.
|Published (Last):||24 December 2006|
|PDF File Size:||10.14 Mb|
|ePub File Size:||1.34 Mb|
|Price:||Free* [*Free Regsitration Required]|
Calculated by taking the current stock price and subtracting yesterday’s closing price. The Board assumes that this description is accurate and has in relevant aspects no reason to take a different view. Circassia has reserved the right to waive these and other conditions for aeroceine of the Offer.
Aerocrine is a medical technology company focused on improving the treatment of patients with inflamed airways.
The Board has, at the written request of Circassia, permitted Circassia to carry out a confirmatory due diligence review of Aerocrine in connection with the preparation of the Offer. The information set out in this press release is announced in accordance with the Swedish Securities Markets Act and the Takeover Rules. In case of any discrepancies between the Swedish and the English text, the Swedish text shall prevail.
The total market value of a company.
Disputes arising from this statement shall be settled exclusively by Swedish courts. The Opinion is attached to this statement. The change of control provisions would be triggered if a party would acquire shares representing more aeeocrine 40 per cent of the votes of Aerocrine. Circassia has not received any other non-public information that could reasonably be expected to affect the price of the Aerocrine share in connection with the review. This press release does not constitute an extension into the United States or any other jurisdiction of the Offer mentioned in this press release.
However, if the entire amount of the loan is prepaid, aerorine penalty would be awrocrine by interest and milestone payments already paid. The total value of the Offer, based on , shares in Aerocrine, amounts to SEK 1,, This press release may not be published, distributed, transmitted or otherwise sent prjces the United States of America including its territories and possessions, every State in the United States and the District of ColumbiaAustralia, Canada, Japan or South Africa or any other state or jurisdiction in which such release, publication or distribution would be unlawful.
This encompasses all issued stock – restricted and free trading. Take the number of shares outstanding and multiple by current price.
Aerocine does not hold any own shares in treasury. The most prevalent stock types are common, preferred, restricted, and fund.
Aerocrine Ab (GM) Historical Data – ACNOY | ADVFN
This statement has been made in a Swedish and English version. The higher the better. About Us Aerocrine AB is a medical technology company focused on the improved management and care of patients with inflammatory airway diseases.
Sales figure represents last 12 months as of March 31, Monitor lets you view up to of your favourite stocks at once and is completely free to use. The acceptance period of the Offer is aerpcrine to commence on May 19, and expire on June 11,subject to any extensions.
Based on the above, the Board unanimously recommends the Aerocrine shareholders to accept the Offer. The Board has taken into account a number of factors that the Board has considered relevant to the assessment of the Offer.
The effect of any such acceleration would be that Aerocrine would be required to pay a prepayments penalty equal to 50 per cent of the amount being prepaid. Measuring airways inflammation helps doctors to diagnose, monitor and optimise therapy for people with inflammatory airway diseases.
Aerocrine AB ser B – Latest price – Charts, news and recommendations
Both are highly reliable and effective tools to assist in the diagnosis and control of airways disease. Circassia is offering SEK 2.
The Information was submitted for publication on May 15, at Both products enable fast and reliable management of airway inflammation and may therefore play a critical role in more effective diagnosis, treatment and follow-up of patients with inflammatory airway diseases such as asthma. Aerocrine shares were listed on the Stockholm Stock Exchange on 15 June